期刊中文名:腦出血(xue)ISSN:2589-238X
該雜志國(guo)(guo)際(ji)簡稱:BRAIN HEMORRHAGES,是由出版商KeAi Communications Co., Ltd.出版的(de)一本致(zhi)力于發(fa)布--研究(jiu)新(xin)成(cheng)果(guo)的(de)的(de)專(zhuan)業(ye)學(xue)術(shu)期刊(kan)。主要(yao)(yao)發(fa)表刊(kan)登有創見的(de)學(xue)術(shu)論(lun)(lun)文文章、行(xing)業(ye)最(zui)新(xin)科(ke)研成(cheng)果(guo),扼要(yao)(yao)報道階段性研究(jiu)成(cheng)果(guo)和重要(yao)(yao)研究(jiu)工作(zuo)的(de)最(zui)新(xin)進(jin)展(zhan),選載對學(xue)科(ke)發(fa)展(zhan)起指導作(zuo)用的(de)綜述與(yu)專(zhuan)論(lun)(lun),促進(jin)學(xue)術(shu)發(fa)展(zhan),為(wei)廣(guang)大(da)讀者服務。該刊(kan)是一本國(guo)(guo)際(ji)優(you)秀雜志,在國(guo)(guo)際(ji)上有很高(gao)的(de)學(xue)術(shu)影響力。
《Brain Hemorrhages》是一本以(yi)English為(wei)主的開(kai)放獲取國(guo)際優秀期刊(kan),中文名稱腦出血,本刊(kan)主要出版、報道(dao)領(ling)域的研(yan)究動態以(yi)及在該領(ling)域取得(de)的各方面的經驗和科研(yan)成果,介紹該領(ling)域有(you)關(guan)本專業(ye)的最(zui)新進展(zhan),探討行(xing)業(ye)發(fa)展(zhan)的思路和方法,以(yi)促進學(xue)術(shu)信(xin)息交流,提高行(xing)業(ye)發(fa)展(zhan)。該刊(kan)已(yi)被(bei)國(guo)際權威(wei)數(shu)據庫SCIE收(shou)錄(lu),為(wei)該領(ling)域相關(guan)學(xue)科的發(fa)展(zhan)起到了良好的推(tui)動作用,也得(de)到了本專業(ye)人員的廣泛認可(ke)。該刊(kan)最(zui)新影(ying)響因子(zi)為(wei)1.3,最(zui)新CiteScore 指數(shu)為(wei)2.9。
Brain Hemorrages is an international medical journal dedicated to the study of cerebral hemorrhage. It was founded by Professor Tang Zhouping's team from the Department of Neurology at Tongji Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, and jointly promoted with the International Association of Hemorrhagic Stroke. This journal is committed to becoming a professional academic exchange platform for global cerebral hemorrhage researchers and clinical doctors, publishing high-quality original research papers, authoritative reviews, and academic newsletters. The content of the magazine covers basic and clinical research on cerebral hemorrhage, including but not limited to cerebral hemorrhage, subarachnoid hemorrhage, aneurysm rupture, cerebral arteriovenous malformation, traumatic cerebral hemorrhage, hematoma, and other topics. The journal emphasizes interdisciplinary research in neurology, neurosurgery, neuroimaging, neurorehabilitation, neuroemergency, and anesthesia to promote scientific progress and innovation in clinical treatment of cerebral hemorrhage
The editor in chief of the magazine is Professor Zhang He from the University of Rome Linda in the United States, and the executive editor is Professor Tang Zhouping. The editorial team is composed of professional publishing and editing personnel to ensure the academic quality and international influence of the journal. The establishment of the magazine fills the gap in academic journals focusing on cerebral hemorrhage research internationally, providing a valuable resource for researchers and clinical doctors worldwide to promote knowledge sharing and the translation and application of scientific research results. With the continuous improvement of the influence of journals, they play an important role in promoting the international discourse power and technological innovation of Chinese academic journals.
按JIF指標學科分區 |
學科:CLINICAL NEUROLOGY
收錄子集:ESCI
分區:Q4
排名:221 / 277
百分位:
20.4% |
按JCI指標學科分區(qu) |
學科:CLINICAL NEUROLOGY
收錄子集:ESCI
分區:Q4
排名:224 / 278
百分位:
19.6% |
JCR分區:JCR分(fen)(fen)區來自科睿唯(wei)(wei)安公司,JCR是一(yi)(yi)個(ge)獨(du)特的(de)多學(xue)(xue)科期(qi)刊(kan)評價工具(ju),為(wei)唯(wei)(wei)一(yi)(yi)提供基(ji)于引文數(shu)據(ju)的(de)統計信息的(de)期(qi)刊(kan)評價資源。每年(nian)發布的(de)JCR分(fen)(fen)區,設置了(le)254個(ge)具(ju)體學(xue)(xue)科。JCR分(fen)(fen)區根(gen)據(ju)每個(ge)學(xue)(xue)科分(fen)(fen)類按照期(qi)刊(kan)當(dang)年(nian)的(de)影響(xiang)因子高低將(jiang)期(qi)刊(kan)平均(jun)分(fen)(fen)為(wei)4個(ge)區,分(fen)(fen)別(bie)為(wei)Q1、Q2、Q3和Q4,各占25%。JCR分(fen)(fen)區中期(qi)刊(kan)的(de)數(shu)量是均(jun)勻分(fen)(fen)為(wei)四個(ge)部分(fen)(fen)的(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Medicine 小類:Surgery | Q2 | 195 / 551 |
64% |
大類:Medicine 小類:Neuroscience (miscellaneous) | Q3 | 27 / 49 |
45% |
大類:Medicine 小類:Neurology (clinical) | Q3 | 235 / 400 |
41% |
大類:Medicine 小類:Neurology | Q3 | 118 / 192 |
38% |
該(gai)雜志(zhi)是一(yi)本國(guo)(guo)際(ji)優(you)秀(xiu)雜志(zhi),在(zai)國(guo)(guo)際(ji)上有(you)較高的(de)學術(shu)影響力,行(xing)業(ye)關注度(du)很(hen)高,已被國(guo)(guo)際(ji)權威數據庫SCIE收錄,該(gai)雜志(zhi)在(zai)綜合專(zhuan)業(ye)領域專(zhuan)業(ye)度(du)認可很(hen)高,對稿件內容的(de)創(chuang)新(xin)性和學術(shu)性要(yao)(yao)求很(hen)高,作為一(yi)本國(guo)(guo)際(ji)優(you)秀(xiu)雜志(zhi),一(yi)般投(tou)稿過審時間(jian)都較長(chang),投(tou)稿過審時間(jian)平均 10 Weeks ,如果想投(tou)稿該(gai)刊要(yao)(yao)做好時間(jian)安(an)排(pai)。版(ban)面(mian)費不祥。該(gai)雜志(zhi)近兩年未(wei)被列入預警(jing)名(ming)單,建議您投(tou)稿。如您想了(le)解(jie)更多投(tou)稿政策及投(tou)稿方案,請咨詢客服。
若(ruo)用戶需要(yao)出(chu)版(ban)服務(wu),請聯系出(chu)版(ban)商。